A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...
Rep. David Schweikert applauded RFK’s concern about obesity and chronic disease, without mentioning his history of ...
Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...
More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...
The U.S. always seems to be in competition with China—economically, technologically, militarily. But how do the two countries ...
Both Roux-en-Y gastric bypass and sleeve gastrectomy reduced health care expenditures after surgery for adults with type 2 ...